Literature DB >> 22840595

Motion management in positron emission tomography/computed tomography for radiation treatment planning.

Valentino Bettinardi1, Maria Picchio, Nadia Di Muzio, Maria Carla Gilardi.   

Abstract

Hybrid positron emission tomography (PET)/computed tomography (CT) scanners combine, in a unique gantry, 2 of the most important diagnostic imaging systems, a CT and a PET tomograph, enabling anatomical (CT) and functional (PET) studies to be performed in a single study session. Furthermore, as the 2 scanners use the same spatial coordinate system, the reconstructed CT and PET images are spatially co-registered, allowing an accurate localization of the functional signal over the corresponding anatomical structure. This peculiarity of the hybrid PET/CT system results in improved tumor characterization for oncological applications, and more recently, it was found to be also useful for target volume definition (TVD) and treatment planning in radiotherapy (RT) applications. In fact, the use of combined PET/CT information has been shown to improve the RT treatment plan when compared with that obtained by a CT alone. A limiting factor to the accuracy of TVD by PET/CT is organ and tumor motion, which is mainly due to patient respiration. In fact, respiratory motion has a degrading effect on PET/CT image quality, and this is also critical for TVD, as it can lead to possible tumor missing or undertreatment. Thus, the management of respiratory motion is becoming an increasingly essential component in RT treatment planning; indeed, it has been recognized that the use of personalized motion information can improve TVD and, consequently, permit increased tumor dosage while sparing surrounding healthy tissues and organs at risk. This review describes the methods used for motion management in PET/CT for radiation treatment planning. The article covers the following: (1) problems caused by organ and lesion motion owing to respiration, and the artifacts generated on CT, PET, and PET/CT images; (2) data acquisition and processing techniques used to manage respiratory motion in PET/CT studies; and (3) the use of personalized motion information for TVD and radiation treatment planning.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840595     DOI: 10.1053/j.semnuclmed.2012.04.001

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  10 in total

1.  Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography.

Authors:  Stephen R Bowen; Larry A Pierce; Adam M Alessio; Chi Liu; Scott D Wollenweber; Charles W Stearns; Paul E Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2014-09-24

2.  Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification.

Authors:  Shouyi Wang; Stephen R Bowen; W Art Chaovalitwongse; George A Sandison; Thomas J Grabowski; Paul E Kinahan
Journal:  Phys Med Biol       Date:  2014-02-07       Impact factor: 3.609

3.  Assessing and accounting for the impact of respiratory motion on FDG uptake and viable volume for liver lesions in free-breathing PET using respiration-suspended PET images as reference.

Authors:  Guang Li; C Ross Schmidtlein; Irene A Burger; Carole A Ridge; Stephen B Solomon; John L Humm
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

4.  Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.

Authors:  S R Bowen; M J Nyflot; C Herrmann; C M Groh; J Meyer; S D Wollenweber; C W Stearns; P E Kinahan; G A Sandison
Journal:  Phys Med Biol       Date:  2015-04-17       Impact factor: 3.609

5.  Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Antoi P W Meeuwis; Charlotte S van der Vos; Martin Gotthardt; Wim J G Oyen; Eric P Visser
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

Review 6.  Aldehyde dehydrogenase 1A1 in stem cells and cancer.

Authors:  Hiroyuki Tomita; Kaori Tanaka; Takuji Tanaka; Akira Hara
Journal:  Oncotarget       Date:  2016-03-08

7.  18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy

Authors:  Kinga Dębiec; Jerzy Wydmański; Izabela Gorczewska; Paulina Leszczyńska; Kamil Gorczewski; Wojciech Leszczyński; Andrea d’Amico; Michał Kalemba
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

8.  Application of FDG-PET/CT in Radiation Oncology.

Authors:  Jun Li; Ying Xiao
Journal:  Front Oncol       Date:  2013-04-11       Impact factor: 6.244

9.  4D-CT Attenuation Correction in Respiratory-Gated PET for Hypoxia Imaging: Is It Really Beneficial?

Authors:  Brandon Driscoll; Douglass Vines; Tina Shek; Julia Publicover; Ivan Yeung; Stephen Breen; David Jaffray
Journal:  Tomography       Date:  2020-06

10.  Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.

Authors:  Yuekai Li; Fengcai Li; Xin Li; Lili Qu; Jiankui Han
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.